JP2006518991A5 - - Google Patents

Download PDF

Info

Publication number
JP2006518991A5
JP2006518991A5 JP2004565747A JP2004565747A JP2006518991A5 JP 2006518991 A5 JP2006518991 A5 JP 2006518991A5 JP 2004565747 A JP2004565747 A JP 2004565747A JP 2004565747 A JP2004565747 A JP 2004565747A JP 2006518991 A5 JP2006518991 A5 JP 2006518991A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
sequence
antibody
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004565747A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006518991A (ja
Filing date
Publication date
Priority claimed from US10/330,773 external-priority patent/US20060040262A1/en
Application filed filed Critical
Publication of JP2006518991A publication Critical patent/JP2006518991A/ja
Publication of JP2006518991A5 publication Critical patent/JP2006518991A5/ja
Pending legal-status Critical Current

Links

JP2004565747A 2002-12-27 2003-12-22 癌における新規組成物および方法 Pending JP2006518991A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/330,773 US20060040262A1 (en) 2002-12-27 2002-12-27 Novel compositions and methods in cancer
PCT/US2003/041389 WO2004060304A2 (en) 2002-12-27 2003-12-22 Novel compositions and methods in cancer

Publications (2)

Publication Number Publication Date
JP2006518991A JP2006518991A (ja) 2006-08-24
JP2006518991A5 true JP2006518991A5 (https=) 2007-02-08

Family

ID=32710826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004565747A Pending JP2006518991A (ja) 2002-12-27 2003-12-22 癌における新規組成物および方法

Country Status (6)

Country Link
US (2) US20060040262A1 (https=)
EP (1) EP1587476A4 (https=)
JP (1) JP2006518991A (https=)
AU (1) AU2003303638A1 (https=)
CA (1) CA2511817A1 (https=)
WO (1) WO2004060304A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101428702B1 (ko) * 2012-10-19 2014-08-12 건국대학교 산학협력단 Hbv의 감염에 의한 간 손상 재생용 조성물

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
JP5087201B2 (ja) 2000-08-03 2012-12-05 ジョンズ・ホプキンス・ユニバーシティ 抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン
US7615380B2 (en) 2001-05-03 2009-11-10 President And Fellows Of Harvard College Methods for modulating an immune response by modulating KRC activity
US9701725B2 (en) 2003-05-05 2017-07-11 The Johns Hopkins University Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2005085865A2 (en) * 2004-03-09 2005-09-15 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb)
CA2594040A1 (en) 2005-01-06 2006-07-13 The Johns Hopkins University Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
EP1874811B1 (en) 2005-04-15 2012-06-13 President and Fellows of Harvard College Methods for modulating bone formation and mineralization by modulating KRC activity
WO2007084791A2 (en) 2006-01-20 2007-07-26 Glenbrook Associates, Inc. System and method for managing context-rich database
ES2627011T3 (es) * 2007-02-02 2017-07-26 Albert Einstein College Of Medicine, Inc. Variantes de corte y empalme específicas de metástasis de Mena y usos de las mismas en el diagnóstico, pronóstico y tratamiento de tumores
US9085638B2 (en) * 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
US8332209B2 (en) * 2007-04-24 2012-12-11 Zinovy D. Grinblat Method and system for text compression and decompression
GB0709092D0 (en) 2007-05-11 2007-06-20 Borrebaeck Carl Diagnosis and method of disease
JP2010528666A (ja) * 2007-06-08 2010-08-26 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント カルボキシエステラーゼ−1多型およびその使用方法
MX341084B (es) 2009-11-02 2016-08-05 Univ Washington Composiciones de nucleasas terapéuticas y métodos.
WO2011088163A1 (en) 2010-01-14 2011-07-21 President And Fellows Of Harvard College Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
US20110178286A1 (en) * 2010-01-21 2011-07-21 Bessetti Joseph G Consumable analytical plasticware comprising high-solubility plastics
US9938575B2 (en) * 2010-08-06 2018-04-10 Rutgers, The State University Of New Jersey Compositions and methods for high-throughput nucleic acid analysis and quality control
ES2666303T3 (es) 2011-04-29 2018-05-03 University Of Washington Composiciones terapéuticas de nucleasa y métodos
AU2012252437B2 (en) * 2011-05-12 2017-05-18 Noviogendix Research B.V. Molecular markers in prostate cancer
HRP20192080T1 (hr) 2013-10-31 2020-02-07 Resolve Therapeutics, Llc Terapeutske fuzije nukleaza-albumine i postupci
US10752896B2 (en) * 2015-09-08 2020-08-25 Sylentis Sau siRNA and their use in methods and compositions for inhibiting the expression of the NRARP gene
CA3029627A1 (en) 2016-07-01 2018-01-04 Resolve Therapeutics, Llc Optimized binuclease fusions and methods
WO2018045155A1 (en) * 2016-09-02 2018-03-08 The Board Of Trustees Of The University Of Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
CA3073537A1 (en) 2017-08-22 2019-02-28 Sanabio, Llc Soluble interferon receptors and uses thereof
CN112533617A (zh) 2018-04-25 2021-03-19 卫理公会医院体系公司 癌症新抗原和其在癌症疫苗和基于tcr的癌症免疫疗法中的效用
CN114605508B (zh) * 2022-05-11 2022-07-29 北京达成生物科技有限公司 能够结合于抗体分子Fc区域的抗体结合蛋白及其应用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US4892890A (en) * 1984-11-01 1990-01-09 G. D. Searle And Company External analgesic compositions
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4777127A (en) * 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
US4938948A (en) * 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
US4956453A (en) * 1985-12-06 1990-09-11 Cetus Corporation Anti-human ovarian cancer immunotoxins and methods of use thereof
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
DE69120146T2 (de) * 1990-01-12 1996-12-12 Cell Genesys Inc Erzeugung xenogener antikörper
US5470967A (en) * 1990-04-10 1995-11-28 The Dupont Merck Pharmaceutical Company Oligonucleotide analogs with sulfamate linkages
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5386023A (en) * 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) * 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE158021T1 (de) * 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5253033A (en) * 1990-12-03 1993-10-12 Raytheon Company Laser radar system with phased-array beam steerer
US5714331A (en) * 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5419966A (en) * 1991-06-10 1995-05-30 Microprobe Corporation Solid support for synthesis of 3'-tailed oligonucleotides
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5644048A (en) * 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US6107475A (en) * 1992-11-17 2000-08-22 Icos Corporation Seven transmembrane receptors
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5637684A (en) * 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5580731A (en) * 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
US5597909A (en) * 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5759776A (en) * 1995-06-05 1998-06-02 California Pacific Medical Center Targets for breast cancer diagnosis and treatment
US5928825A (en) * 1995-06-26 1999-07-27 Fuji Xerox Co., Ltd. Toner for developing electrostatic latent images
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
WO1999033992A1 (en) * 1997-12-31 1999-07-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Murine intracisternal a particle constitutive transport elements and uses thereof
US6153441A (en) * 1998-02-17 2000-11-28 Smithkline Beecham Corporation Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof
US20020151681A1 (en) * 1999-03-12 2002-10-17 Rosen Craig A. Nucleic acids, proteins and antibodies
WO2001092581A2 (en) * 2000-05-26 2001-12-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
EP1354065A2 (en) * 2001-01-18 2003-10-22 The Regents of The University of California High through-put cloning of protooncogenes
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
AU2003278725A1 (en) * 2002-08-27 2004-03-19 Bristol-Myers Squibb Company Polynucleotide predictor set for identifying protein tyrosine kinase modulators

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101428702B1 (ko) * 2012-10-19 2014-08-12 건국대학교 산학협력단 Hbv의 감염에 의한 간 손상 재생용 조성물

Similar Documents

Publication Publication Date Title
JP2006518991A5 (https=)
JP2009519002A5 (https=)
CA2488404A1 (en) Genes and polypeptides relating to human colon cancers
RU2008114318A (ru) Идентификация опухолевых антигенов для диагностики и терапии
CN101632833B (zh) 一种前列腺癌相关的基因及其用途
KR20110014979A (ko) 항바이러스 요법
KR20110036610A (ko) 신규 온코진 nrf2
CN105659085A (zh) 预测受试者对多激酶抑制剂的反应的基因表达标志及其使用方法
WO2012015836A1 (en) Highly potent peptides to control cancer and neurodegenerative diseases
JP2009523004A5 (https=)
KR102574799B1 (ko) 마약 중독 또는 금단증상 진단용 바이오마커 조성물 및 마약 중독 또는 금단증상 진단용 키트
CN105648076B (zh) Nudt11基因及其表达产物作为子宫肌瘤的诊治靶标
CN105886625B (zh) Chka基因在制备食管癌诊治产品中的应用
KR20250123230A (ko) 유전자 발현 검정을 이용한 펩티드 수용체 방사선요법의 예측
CN100571785C (zh) Annexin A3与癌症的铂类化疗药物耐药性的相关性
CN111154865B (zh) 帕金森生物标志物及其在制备检测产品中的应用
CN107022635A (zh) Acadl基因及其表达产物在制备腹主动脉瘤诊治产品中的应用
CN110305963A (zh) 一种食管癌分子标志物及其应用
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
CN112877440B (zh) 生物标志物在预测肝癌复发中的应用
CN105838797B (zh) 一种诊治食管癌的分子标志物
CN105506169B (zh) 子宫肌瘤诊治标志物
JP5316749B2 (ja) シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット
CN113528667A (zh) 一种骨巨细胞瘤的诊断方法
CN105506170B (zh) Sav1基因作为子宫肌瘤诊治标志物的用途